Software
AmpliconSuite is a set of 10 interoperable open-source tools for analysing focal amplifications, from raw reads to classified, visualised structures. I founded the project and lead its development.
Tools
| Tool | What it does | Role |
|---|---|---|
| AmpliconSuite-pipeline | End-to-end detection, reconstruction and classification from WGS | lead |
| AmpliconClassifier | Calls ecDNA, BFB and other amplification types | lead |
| AmpliconRepository.org | Community-editable database of ecDNA annotations | project lead |
| AmpliconArchitect | Breakpoint graphs of amplified regions from short reads | maintainer |
| AmpliconReconstructor | Joins NGS and optical maps to resolve full structures | lead |
| CoRAL | ecDNA reconstruction from long reads | co-developer |
| CycleViz | Circular and linear structure visualization | lead |
| FaNDOM | Fast optical genome map alignment | co-lead |
| ecSimulator | Simulated ecDNA structures for benchmarking | lead |
| CycleExtractor | Fast resolution of ecDNA sequence from the breakpoint graph | contributor |
Usage
Large-scale studies (50 or more samples) that used AmpliconArchitect or AmpliconSuite, counted by samples analysed and plotted by publication date. Preprints are included. Hover a step to see the study.
Some cohorts were analysed in more than one study.
Large-scale studies using AmpliconSuite tools
Published studies and preprints with 50 or more samples.
| Date | Study | Cohort | Samples |
|---|---|---|---|
| Oct 2026 | Luebeck et al., Nature Methods | Cancer cell lines (CCLE) | 392 |
| Aug 2026 | ElHarouni et al., Nature | HCMI models and tumors | 989 |
| Jul 2026 | MacLennan et al., bioRxiv | Cervical cancer (HTMCP) | 118 |
| Jul 2026 | Yesudhas et al., bioRxiv | Bladder cancer (TCGA rerun) | 408 |
| May 2026 | Chmelova et al., Nature Communications | Ductal carcinoma in situ | 113 |
| Apr 2026 | Moreno-Rodriguez et al., Genome Biology | Prostate cancer (WCDT + CASCADE) | 193 |
| Mar 2026 | Nones et al., Genome Medicine | Small cell lung cancer | 76 |
| Feb 2026 | Culliford et al., Molecular Cancer Research | Renal cell carcinoma | 164 |
| Dec 2025 | Wong et al., bioRxiv | Glioblastoma (ecDNA atlas / ecLego3) | 55 |
| Dec 2025 | Yu et al., medRxiv | Acute myeloid leukemia (ATLAS/MEASURE) | 255 |
| Dec 2025 | Kim et al., Nature | Breast cancer | 1,364 |
| Dec 2025 | Pribus et al., bioRxiv | Breast cancer (ecDNAInspector) | 231 |
| Oct 2025 | Hokazono et al., Gastric Cancer | Gastric cancer | 81 |
| Sep 2025 | Xiao et al., Cell Genomics | Bladder cancer | 114 |
| Sep 2025 | Li et al., Cell Stem Cell | Pancreatic organoids | 260 |
| Aug 2025 | Kenkre et al., bioRxiv | Pediatric PDX models | 338 |
| Aug 2025 | Mout et al., bioRxiv | Prostate cancer | 69 |
| Jul 2025 | Khandekar et al., bioRxiv | Lung cancer | 1,216 |
| Jul 2025 | Ewing et al., Nature Communications | Ovarian cancer | 324 |
| Jun 2025 | Zhang et al., ResearchSquare | Testicular cancer | 252 |
| Jun 2025 | Sridhar et al., medRxiv | PanPedCan | 3,796 |
| May 2025 | Akdemir et al., bioRxiv | Glioma | 93 |
| May 2025 | Yost et al., Nature Genetics | Pan-cancer 3D genome (TCGA) | 169 |
| May 2025 | Kinnersley et al., Nature Communications | Diffuse glioma (100kGP) | 403 |
| Apr 2025 | Mayr et al., Cancer Cell | Glioma | 579 |
| Mar 2025 | Lv et al., Cancer Discovery | Urothelial carcinoma | 1,411 |
| Jan 2025 | Valle-Inclan et al., Cell | Osteosarcoma | 356 |
| Jan 2025 | Zheng et al., iScience | Urothelial carcinoma | 199 |
| Nov 2024 | Bailey et al., Nature | Genomics England | 14,778 |
| Oct 2024 | Kim et al., Nature Genetics | Pan-cancer (TCGA, PCAWG, Hartwig) | 8,060 |
| Oct 2024 | O'Neill et al., Cell Genomics | Pan-cancer long read (matched WGS) | 189 |
| Oct 2024 | Nguyen et al., Nature | Urothelial carcinoma | 71 |
| Aug 2024 | Lv et al., Theranostics | Urothelial carcinoma | 80 |
| Aug 2024 | Nunes et al., Nature | Colorectal cancer | 1,063 |
| Aug 2024 | Cornish et al., Nature | Colorectal cancer | 1,761 |
| Aug 2024 | Fessler et al., NAR Cancer | Cancer cell lines | 468 |
| Jul 2024 | Zhang et al., Neoplasia | Hematological malignancies | 208 |
| May 2024 | Ng et al., Nature Communications | Esophageal squamous cell carcinoma | 710 |
| May 2024 | Choudhuri et al., Cancer Discovery | Small cell lung cancer | 51 |
| Apr 2024 | Chen et al., Genome Medicine | T cell lymphoma | 71 |
| Feb 2024 | Wang et al., Nature Communications | GCAP Pancancer WES benchmark | 386 |
| Feb 2024 | Chen et al., Nature | Hepatocellular carcinoma (HPV-driven) | 494 |
| Nov 2023 | Chapman et al., Nature Genetics | Medulloblastoma | 481 |
| Oct 2023 | Rodriguez-Fos et al., Cell Genomics | Neuroblastoma | 150 |
| Apr 2023 | Luebeck et al., Nature | Barrett's and Esophageal adenocarcinoma | 286 |
| Apr 2023 | Pongor et al., Cancer Discovery | Small cell lung cancer | 143 |
| Feb 2023 | Zhong et al., Briefings in Bioinformatics | eccDNA Atlas | 319 |
| Oct 2022 | Cui et al., Nature Communications | Esophageal squamous cell carcinoma | 528 |
| Apr 2022 | Peng et al., Oncogene | eccDNAdb | 191 |
| Feb 2022 | Bergstrom et al., Nature | Pan-cancer (clustered mutations) | 2,583 |
| Dec 2021 | Pang et al., Clinical Cancer Research | Head-and-neck cancer (HPV-driven) | 72 |
| Nov 2021 | Zhao et al., Nature Communications | Gastric cardia adenocarcinoma | 72 |
| Aug 2020 | Kim et al., Nature Genetics | Pan-cancer (TCGA) | 3,212 |
| Jan 2019 | Deshpande et al., Nature Communications | AmpliconArchitect paper | 68 |
| Mar 2017 | Turner et al., Nature | NCI-60 | 113 |